EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Comparison of Ferric Carboxymaltose and Fractionated Iron Sucrose in Iron Deficiency Anemia: Toward Optimizing Patient Outcomes

Noor Kareem Wanas, Bassim I. Mohammad, Doaa Husam Abdulqader

Annals of the College of Medicine Mosul · 2025

DOI: 10.33899/acmm.v47i2.60228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the College of Medicine Mosul, 2025. Verfasst von Noor Kareem Wanas und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Iron deficiency anemia (IDA) is a widespread hematologic condition characterized by low hemoglobin levels. Intravenous (IV) iron is used for replenishing iron stores. Iron sucrose is administered in multiple low-dose infusions and recognized for its favourable safety and efficacy profile. Ferric carboxymaltose (FCM), a newer IV formulation, permits higher iron doses in a single infusion and may improve patient adherence. However, FCM is linked to a high incidence of adverse effects.

Aims

To compare the efficacy of IV FCM and iron sucrose in improving hemoglobin levels in patients with IDA and the number of hospital visits, and to assess the safety of ferric carboxymaltose Method: In this study, 30 patients diagnosed with IDA at Aldiwaniay Teaching Hospital. 15 patients received iron sucrose, and 15 received FCM. Hematologic response was evaluated via complete blood count performed before treatment and two weeks following the final infusion.

Result

Iron sucrose produced a modest yet statistically significant improvement in hemoglobin levels compared to FCM. Nevertheless, FCM was associated with fewer hospital visits, offering a benefit in terms of treatment convenience. Notably, the FCM group experienced a high adverse event.

Conclusion

While iron sucrose demonstrated slightly superior hematologic efficacy, FCM remains an alternative, particularly in settings where resource optimization and patient accessibility are central considerations.

Zitieren

APA

Wanas, N. K., Mohammad, B. I., & Abdulqader, D. H. (2025). Therapeutic Comparison of Ferric Carboxymaltose and Fractionated Iron Sucrose in Iron Deficiency Anemia: Toward Optimizing Patient Outcomes. Annals of the College of Medicine Mosul. https://doi.org/10.33899/acmm.v47i2.60228

Vancouver

Wanas NK, Mohammad BI, Abdulqader DH. Therapeutic Comparison of Ferric Carboxymaltose and Fractionated Iron Sucrose in Iron Deficiency Anemia: Toward Optimizing Patient Outcomes. Annals of the College of Medicine Mosul. 2025. doi:10.33899/acmm.v47i2.60228

BibTeX
@article{Wanas2025,
  author = {Wanas, Noor Kareem and Mohammad, Bassim I. and Abdulqader, Doaa Husam},
  title = {Therapeutic Comparison of Ferric Carboxymaltose and Fractionated Iron Sucrose in Iron Deficiency Anemia: Toward Optimizing Patient Outcomes},
  journal = {Annals of the College of Medicine Mosul},
  year = {2025},
  doi = {10.33899/acmm.v47i2.60228}
}
Kostenlos starten →